APPARATUS FOR REMOVING CHEMOTHERAPY COMPOUNDS FROM BLOOD

(19)

(11)

EP 2 776 086 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	06.03.2019 Bulletin 2019/10

(45)	Mention of the grant of the patent:
	26.12.2018 Bulletin 2018/52

(21)	Application number: 12847108.3

(22)	Date of filing: 07.11.2012

(51)

International Patent Classification (IPC):

A61M 1/34^(2006.01)
B01J 20/28^(2006.01)
B01J 20/26^(2006.01)
B01J 20/32^(2006.01)
C01B 32/372^(2017.01)

A61M 1/36^(2006.01)
B01J 20/20^(2006.01)
B01J 20/30^(2006.01)
C01B 32/354^(2017.01)

(86)	International application number:
	PCT/US2012/064002

(87)	International publication number:
	WO 2013/070809 (16.05.2013 Gazette 2013/20)

(54)	APPARATUS FOR REMOVING CHEMOTHERAPY COMPOUNDS FROM BLOOD VORRICHTUNG ZUR ENTFERNUNG VON CHEMOTHERAPEUTISCHEN VERBINDUNGEN AUS DEM BLUT APPAREIL POUR RETIRER DES COMPOSÉS DE CHIMIOTHÉRAPIE À PARTIR DU SANG

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

07.11.2011 US 201161556819 P

(43)	Date of publication of application:
	17.09.2014 Bulletin 2014/38

(60)	Divisional application:
	17176952.4 / 3241576

(73)	Proprietor: Delcath Systems, Inc.
	New York, NY 10019 (US)

(72)	Inventors:
	JOHNSTON, Daniel, S. Trappe, PA 19426 (US) CHAMMAS, Jacques Walpole, MA 02081 (US) APPLING, William M. Granville, NY 12832 (US) BARTON, Samantha Hudson Falls, NY 12839 (US)

(74)	Representative: J A Kemp
	14 South Square Gray's Inn London WC1R 5JJ London WC1R 5JJ (GB)

(56)

References cited: :

WO-A1-02/059039
WO-A1-2011/056181
US-A- 4 048 064
US-A- 4 081 402
US-A- 4 221 695
US-A- 5 059 654
US-A1- 2005 279 696

WO-A1-2011/056181
US-A- 3 953 360
US-A- 4 048 064
US-A- 4 169 051
US-A- 4 221 695
US-A- 5 312 586
US-A1- 2005 279 696

Johan Tijssen ET AL: "A Hemoperfusion Using Coated Activated Carbon A Hemoperfusion Column Based on Activated Carbon Granules Coated with an Ultrathin Membrane of Cellulose Acetate", , 1 February 1979 (1979-02-01), pages 11-14, XP055257977, Retrieved from the Internet: URL:http://onlinelibrary.wiley.com/doi/10. 1111/j.1525-1594.1979.tb03797.x/pdf [retrieved on 2016-03-14]
DAVID A. AUGUST ET AL: "Hepatic Artery Infusion of Doxorubicin with Hepatic Venous Drug Extraction", JOURNAL OF SURGICAL RESEARCH., vol. 56, no. 6, 1 June 1994 (1994-06-01), pages 611-619, XP055276631, US ISSN: 0022-4804, DOI: 10.1006/jsre.1994.1097
YUSHIN G ET AL: "Mesoporous carbide-derived carbon with porosity tuned for efficient adsorption of cytokines", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 27, no. 34, 1 December 2006 (2006-12-01), pages 5755-5762, XP027951105, ISSN: 0142-9612 [retrieved on 2006-12-01]
YUSHIN ET AL.: 'Mesoporous carbide-derived carbon with porosity tuned for efficient adsorption of cytokines''.' BIOMATERIALS vol. 27, no. 34, 01 January 2006, pages 5755 - 5762, XP027951105
TIJSSEN ET AL.: 'A Hemoperfusion Column Based on Activated Carbon Granules Coated with an Ultrathin Membrane of Cellulose Acetate''.' ARTIFICIAL ORGANS. vol. 3, no. 1, 01 February 1979, pages 11 - 14, XP055257977

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).